Nuveen’s Alkermes ALKS Stock Holding History

Nuveen’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-38,400	Closed	-$1K	–	3356
2021 Q1	$1K	Sell	38,400 -63,800	-62%	-$1.31M	﹤0.01%	3359
2020 Q4	$2K	Buy	+102,200	New	+$1.87M	﹤0.01%	3298

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Nuveen's ALKS Position: Q2 2026 in Review

Nuveen reduced its Alkermes (ALKS) stake by 5.5% in Q2 2026, selling an estimated $5.33M and leaving 2,324,197 shares worth $122M. The position accounts for 0.03% of the portfolio, ranked #370.

Nuveen first reported a position in ALKS in Q2 2013 and has held it in 53 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

Nuveen held 2,324,197 shares of Alkermes worth $122M as of Q2 2026.
Nuveen sold 136,372 Alkermes shares in Q2 2026, an estimated $5.33M.
Alkermes made up 0.03% of Nuveen's portfolio in Q2 2026, its #370 holding.
Nuveen first reported a position in Alkermes in Q2 2013 and has held it in 53 quarters since.
424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.